Priority Date: 02.06.16 (US 201662344870P)

COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION

  • Application ID: EP17807296
  • Status: Request for examination was made

Attorney

operating since 1878
Headquarter in Boston and 11 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 227 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 02.06.2016 - Priority Date (US 201662344870P)
  • 07.12.2017 - Publication A1 (WO2017210132)
  • 10.04.2019 - Publication A1 (EP3463315)

IPC Classification